Drug Information

Drug General Information
Drug ID
D04HQK
Former ID
DNC012155
Drug Name
N-(5-Sulfamoyl-[1,3,4]thiadiazol-2-yl)-benzamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526241]
Formula
C9H8N4O3S2
Canonical SMILES
C1=CC=C(C=C1)C(=O)NC2=NN=C(S2)S(=O)(=O)N
InChI
1S/C9H8N4O3S2/c10-18(15,16)9-13-12-8(17-9)11-7(14)6-4-2-1-3-5-6/h1-5H,(H2,10,15,16)(H,11,12,14)
InChIKey
PMNNJWNEWDGYIV-UHFFFAOYSA-N
PubChem Compound ID
394898
Target and Pathway
Target(s) Carbonic anhydrase IV Target Info Inhibitor [526241]
KEGG Pathway Nitrogen metabolism
Proximal tubule bicarbonate reclamation
Reactome Erythrocytes take up carbon dioxide and release oxygen
Erythrocytes take up oxygen and release carbon dioxide
Reversible hydration of carbon dioxide
WikiPathways Reversible Hydration of Carbon Dioxide
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes
References
Ref 526241J Med Chem. 2002 Jan 17;45(2):312-20.Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.
Ref 526241J Med Chem. 2002 Jan 17;45(2):312-20.Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.